期刊文献+

p53蛋白和Ki-67在恶性纤维组织细胞瘤组织中的表达及意义 被引量:1

Relationship and prognostic significance between p53 protein and Ki-67 expressions in patients with malignant fibrous histiolytoma
下载PDF
导出
摘要 目的:研究p53蛋白和Ki-67在恶性纤维组织细胞瘤(malignant fibrous histi-ocytoma,MFH)组织中的表达及其临床意义。方法:应用免疫组化SP法检测50例MFH中p53和Ki-67的表达。结果:p53蛋白和Ki-67在MFH中表达阳性率分别为32·0%(16/50)和56·0%(28/50);在有复发转移的患者中,p53蛋白和Ki-67的阳性率分别为48%(12/25)和68%(17/25);在无复发转移的患者中,p53蛋白和Ki-67的阳性率分别为16·0%(4/25)和40·0%(10/25);生存期<5年的患者中,p53蛋白和Ki-67的阳性率分别为48·1%(13/27)和70·4%(19/27),生存期>5年的患者中p53蛋白和Ki-67的阳性率分别为17·4%(4/23)和39·1%(9/23)。p53蛋白和Ki-67与患者的复发转移及生存期显著相关,P<0·05。p53蛋白与Ki-67的表达关系密切,P<0·05。结论:p53蛋白和Ki-67的高表达与MFH的复发转移及患者生存期相关,两者的表达关系密切,并可作为MFH患者预后判断的两个指标。肿瘤防治杂志,2005,12(19) OBJECTIVE: To study p53 protein and Ki-67 expressions in patients with malignant fibrous histioeytom-MFH and their clinical significance. METHODS: The SP immunohistochemical method was employed to examine the expressions of p53 protein and Ki-67 in 50 cases of MFH. RESULTS: The positive rates of p53 protein and Ki-67 expressions were 32.0% (16/50) and 56.0% (28/50). respectively. In cases of recurrence and metastasis, the positive rates of p53 protein and Ki-67 expressions were 48.0% (12/25) and 68.0%(17/25), respectively. In cases of nonrecurfence and nonmetastasis, the positive rates of p53 protein and Ki-67 expressions were 16.0%(4/25) and 40.0%(10/25), respectively. In less than 5 year survival cases, the positive rates of p53 protein and Ki-67 expressions were 48. 1%(13/27) and 70.4%(19/27). In over 5 year survival cases, the positive rates of p53 protein and Ki-67 expressions were 17.4 % (4/23) and 39. 1 % (9/23). The expressions of p53 protein and Ki-67 were related to the recurrence and metastasis of MFH, and survival rate of the patients, P〈0.05. The expression of p53 protein was closely related to that of Ki-67,P〈0. 05. CONCLUSIONS: The over expressions of p53 and Ki-67 are related to recurrence and metastasis of MFH, and survival rate of the patients. The expressions of both of them are colosly related and can serve as two markers of judging prognosis of the patients.
出处 《肿瘤防治杂志》 2005年第19期1492-1494,共3页 China Journal of Cancer Prevention and Treatment
关键词 组织细胞瘤 纤维/病理学 蛋白质P53 KI-67抗原 免疫组织化学 预后 histioeytoma,fibrous pathology protein p53 Ki-67 antigen immunohistoehemistry prognosis
  • 相关文献

参考文献7

二级参考文献8

  • 1吕有勇,高崇峰,崔建涛,孙梅程,金泉.胃癌中MTS1/p16基因缺失及表达异常的研究[J].中华肿瘤杂志,1996,18(3):189-191. 被引量:88
  • 2[1]Fletcher CDM, Unni KK, Mertens F, eds. World Health Orgnization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon:IARC Press, 2002 被引量:1
  • 3[2]Somasundaram K.Tumor suppressor p53: regulation and function. Front Biosci,2000, 5: d424 被引量:1
  • 4[3]Mobley SR, Liu TJ, Hudson JM et al. In vitro growth suppression by adenovial transduction of p21 and p16 in squamous cell carcinoma of the head and neck:a research model for combination gene therapy. Arch Otolaryngol Head Neck Surg, 1998,124:88 被引量:1
  • 5[4]Reed JA, Loganzo F Jr, Shea CR et al. Loss of expression of the p16/cyclin-dependent kinase inhabitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res,1995,55:2713 被引量:1
  • 6[5]Zhao R,Gish K, Murphy M et al . Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev,2000,14:981 被引量:1
  • 7桂律,李如昌,林梅绥,许祖德,罗金芳,叶宣光.膀胱移行细胞癌bcl-2、p53及Ki-67的表达[J].中华实验外科杂志,2000,17(6):585-585. 被引量:7
  • 8王岩,刘晓霞,侯正文,柳春晖,马秀萍,陈丽萍,贾支红,方虹.基质金属蛋白酶及其抑制剂在乳腺癌转移、浸润中的作用[J].临床与实验病理学杂志,2002,18(3):273-275. 被引量:12

共引文献120

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部